Exercise and airway clearance education for NTM lung disease
Part of Lungs & breathing clinical trials.
This trial studies whether a program of exercise and airway clearance education helps people with nontuberculous mycobacterial (NTM) lung disease. It aims to improve breathing and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- You have been diagnosed with NTM lung disease (a type of lung infection) following standard medical guidelines.
- Your infection is caused by one of these NTM bacteria: M. avium, M. intracellulare, M. abscessus, M. massiliense, or M. kansasii.
- You are able to take part in a pulmonary rehabilitation (breathing exercise) and airway clearance training program.
- You agree to sign a consent form to participate.
- You are not pregnant or breastfeeding, and you do not have severe mobility problems, a nerve/muscle disorder, or a history of coughing up large amounts of blood.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a structured exercise program can improve symptoms and quality of life in people with nontuberculous mycobacterial (NTM) lung disease. If you have a confirmed NTM lung infection and are having respiratory symptoms, this study may help you build strength and better manage your condition.
This study looks at how your diet (nutrition) and your immune system's T cells (a type of white blood cell) may affect the progression of a lung infection caused by nontuberculous mycobacteria (NTM). Researchers will use samples from a bronchoscopy to check your immune activity and nutrition, which may help understand the disease and guide better care.
This is a research registry that collects information from adults diagnosed with nontuberculous mycobacterial (NTM) lung disease. It may help doctors better understand the disease and improve care over time.
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
This trial tests a special exercise and breathing program for people who still have lung problems after being treated for tuberculosis. If you join, you may get this program, which could help you breathe easier and do more in your daily life.
Hear when a new Nontuberculous Mycobacterial Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.